部长称英美制药协议将促进生命科学投资
路透伦敦12月1日 - 英国科技大臣利兹-肯德尔(Liz Kendall)周一表示,与美国达成的一项新的制药协议 (link),将鼓励生命科学公司继续在英国投资和创新。
"肯德尔在一份声明中说:"这项至关重要的协议将确保英国患者能够更快地获得他们所需的尖端药物,而我们世界领先的英国公司也将继续开发能够改变生命的治疗方法。
"肯德尔补充说:"这也将促使和激励生命科学公司继续在英国本土进行投资和创新。
英国政府表示,根据协议,它还将把用于创新、安全和有效治疗的支出提高约 25%。
(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)
At the request of the copyright holder, you need to log in to view this content
LOGIN / SIGN UPDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.